Jennifer A Deal1, Melinda C Power2, Priya Palta3, Alvaro Alonso4, Andrea L C Schneider5, Kelly Perryman6, Karen Bandeen-Roche7, A Richey Sharrett1. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC. 3. Division of General Medicine, Department of Medicine, Columbia University Medical Center, New York, New York. 4. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. 5. Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland. 6. Department of Neurosurgery, Florida Cancer Specialists and Research Institute, Palm Beach Gardens, Florida. 7. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abstract
OBJECTIVES: Understanding how dementia risk is impacted by timing of smoking cessation has public health implications for prevention efforts. We investigated the relationship of cigarette smoking and cessation with dementia risk and cognitive decline in the Atherosclerosis Risk in Communities (ARIC) study. DESIGN: Ongoing prospective cohort study. SETTING: Begun in 1987-1989, ARIC was conducted in four US communities. PARTICIPANTS: A total of 13 002 men and women (25% African American) aged 52 to 75 years. MEASUREMENTS: All-cause dementia was defined using standardized algorithms incorporating longitudinal cognitive data, proxy report, and hospital and death certificate dementia codes. Cognitive decline was measured using a composite cognitive score created from three tests measured at two time points (1996-1998 and 2011-2013). Smoking and cessation status were defined by self-report using data from 1987-1989 (visit 1) and 1996-1998 (visit 4). Incident dementia risk and differences in cognitive change by smoking status were estimated with Cox proportional hazards and linear regression models, respectively. To address smoking-related attrition, cognitive scores were imputed for living participants with incomplete cognitive testing. RESULTS: The proportion of never, former, and current smokers was 44%, 41%, and 14%; 79% of former smokers quit 9 years or more before baseline. A total of 1347 participants developed dementia. After adjustment, compared with never smoking, the hazard ratio for all-cause dementia for current smoking was 1.33 (95% confidence interval [CI] = 1.12-1.59) and for recent quitting (<9 y before baseline) was 1.24 (95% CI = 1.01-1.52). Quitting 9 years or more before baseline was not associated with dementia. We found no differences in rates of cognitive decline by smoking status. CONCLUSION: Although quitting at any time suggested benefit, dementia risk depended on time since smoking cessation. Our study highlights the importance of early midlife cessation to decrease dementia risk. J Am Geriatr Soc 68:337-345, 2020.
OBJECTIVES: Understanding how dementia risk is impacted by timing of smoking cessation has public health implications for prevention efforts. We investigated the relationship of cigarette smoking and cessation with dementia risk and cognitive decline in the Atherosclerosis Risk in Communities (ARIC) study. DESIGN: Ongoing prospective cohort study. SETTING: Begun in 1987-1989, ARIC was conducted in four US communities. PARTICIPANTS: A total of 13 002 men and women (25% African American) aged 52 to 75 years. MEASUREMENTS: All-cause dementia was defined using standardized algorithms incorporating longitudinal cognitive data, proxy report, and hospital and death certificate dementia codes. Cognitive decline was measured using a composite cognitive score created from three tests measured at two time points (1996-1998 and 2011-2013). Smoking and cessation status were defined by self-report using data from 1987-1989 (visit 1) and 1996-1998 (visit 4). Incident dementia risk and differences in cognitive change by smoking status were estimated with Cox proportional hazards and linear regression models, respectively. To address smoking-related attrition, cognitive scores were imputed for living participants with incomplete cognitive testing. RESULTS: The proportion of never, former, and current smokers was 44%, 41%, and 14%; 79% of former smokers quit 9 years or more before baseline. A total of 1347 participants developed dementia. After adjustment, compared with never smoking, the hazard ratio for all-cause dementia for current smoking was 1.33 (95% confidence interval [CI] = 1.12-1.59) and for recent quitting (<9 y before baseline) was 1.24 (95% CI = 1.01-1.52). Quitting 9 years or more before baseline was not associated with dementia. We found no differences in rates of cognitive decline by smoking status. CONCLUSION: Although quitting at any time suggested benefit, dementia risk depended on time since smoking cessation. Our study highlights the importance of early midlife cessation to decrease dementia risk. J Am Geriatr Soc 68:337-345, 2020.
Authors: Melinda C Power; Jennifer A Deal; A Richey Sharrett; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Neurology Date: 2015-01-28 Impact factor: 9.910
Authors: Andreea Monica Rawlings; Yingying Sang; Albert Richey Sharrett; Josef Coresh; Michael Griswold; Anna Maria Kucharska-Newton; Priya Palta; Lisa Miller Wruck; Alden Lawrence Gross; Jennifer Anne Deal; Melinda Carolyn Power; Karen Jean Bandeen-Roche Journal: Eur J Epidemiol Date: 2016-09-12 Impact factor: 8.082
Authors: Ewoud J van Dijk; Niels D Prins; Henri A Vrooman; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: Stroke Date: 2008-07-17 Impact factor: 7.914
Authors: Kay Deckers; Martin P J van Boxtel; Olga J G Schiepers; Marjolein de Vugt; Juan Luis Muñoz Sánchez; Kaarin J Anstey; Carol Brayne; Jean-Francois Dartigues; Knut Engedal; Miia Kivipelto; Karen Ritchie; John M Starr; Kristine Yaffe; Kate Irving; Frans R J Verhey; Sebastian Köhler Journal: Int J Geriatr Psychiatry Date: 2014-12-12 Impact factor: 3.485
Authors: Johannes B Scheppach; Josef Coresh; Aozhou Wu; Rebecca F Gottesman; Thomas H Mosley; David S Knopman; Morgan E Grams; A Richey Sharrett; Silvia Koton Journal: Am J Kidney Dis Date: 2020-05-16 Impact factor: 8.860
Authors: Emmanuel E Garcia Morales; James Ting; Alden L Gross; Joshua F Betz; Kening Jiang; Simo Du; Melinda C Power; Nicholas S Reed; A Richey Sharrett; Frank R Lin; Jennifer A Deal Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-03-01 Impact factor: 8.961
Authors: C R Lewis; J S Talboom; M D De Both; A M Schmidt; M A Naymik; A K Håberg; T Rundek; B E Levin; S Hoscheidt; Y Bolla; R D Brinton; M Hay; C A Barnes; E Glisky; L Ryan; M J Huentelman Journal: Sci Rep Date: 2021-05-13 Impact factor: 4.379
Authors: Rongbin Xu; Shuai Li; Shanshan Li; Ee Ming Wong; Melissa C Southey; John L Hopper; Michael J Abramson; Yuming Guo Journal: Environ Health Perspect Date: 2021-08-30 Impact factor: 9.031
Authors: Simone N De Luca; Kurt Brassington; Stanley M H Chan; Aleksandar Dobric; Kevin Mou; Huei Jiunn Seow; Ross Vlahos Journal: J Neuroinflammation Date: 2022-03-29 Impact factor: 8.322
Authors: Becky R Horst; Joyla A Furlano; Michelle Y S Wong; Sabrina D Ford; Brenna B Han; Lindsay S Nagamatsu Journal: Front Public Health Date: 2021-06-08